Sovaldi (sofosbuvir) is remarkable for its efficacy ... Whitehead says the rebate provided by industry to the NHS will be £400 million this year, and could be as high as £1 billion next year.
A medical organisation is trying to overturn Gilead Sciences' European patent for hepatitis C drug Sovaldi so cut-price generics can be made available. The Paris-based Médecins du Monde (MDM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback